Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Advanced Medical Solutions Group plc    AMS   GB0004536594

ADVANCED MEDICAL SOLUTIONS GROUP PLC (AMS)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201520162017201820192020
Sales68,682,696,9102110118
EBITDA19,922,129,530,333,035,9
Operating profit (EBIT)17,419,525,427,229,231,4
Pre-Tax Profit (EBT)17,019,125,327,329,632,6
Net income14,115,720,121,623,225,8
P/E ratio27,130,033,932,930,928,3
EPS (GBp )6,687,389,3610,210,811,8
Dividend per Share (GBp )0,800,921,101,141,231,65
Yield0,44%0,41%0,35%0,34%0,37%0,49%
Reference price (GBp )181.25221.75317.75334.5334.5334.5
Announcement Date03/16/2016
07:00am
03/14/2017
07:52am
03/14/2018
06:01am
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201520162017201820192020
Debt------
Finance34,251,162,582,498,9100
Operating income (EBITDA)19,922,129,530,333,035,9
Leverage
(Debt/EBITDA)
------
Capital Expenditure1,911,522,902,681,652,03
Book Value Per Share (BVPS)49,6 PNC59,1 PNC71,7 PNC80,5 PNC85,3 PNC101 PNC
Cash Flow per Share10,1 PNC9,33 PNC7,92 PNC8,20 PNC9,20 PNC10,0 PNC
Announcement Date03/16/2016
07:00am
03/14/2017
07:52am
03/14/2018
06:01am
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 713 M GBP -
Entreprise Value (EV) 630 M GBP 614 M GBP
Valuation 2018e 2019e
P/E ratio (Price / EPS) 32,9x 30,9x
Capitalization / Revenue 6,96x 6,46x
EV / Revenue 6,16x 5,56x
EV / EBITDA 20,8x 18,6x
Yield (DPS / Price) 0,34% 0,37%
Price to book (Price / BVPS) 4,16x 3,92x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 26,5% 26,5%
operating Leverage (Delta EBIT / Delta Sales) 1,25x 0,96x
Net Margin (Net Profit / Revenue) 21,1% 21,0%
ROA (Net Profit / Asset) 12,2% -
ROE (Net Profit / Equities) 13,3% 12,6%
Rate of Dividend 11,3% 11,4%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   2,62% 1,50%
Cash Flow / Sales 17,1% 17,8%
Capital Intensity (Assets / Sales) 1,73x -
Financial Leverage (Net Debt / EBITDA) -2,72x -3,00x
EPS & Dividend